Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements

被引：28

作者：

Dejoie, Thomas ^{[1
]}

Corre, Jill ^{[2
]}

Caillon, Helene ^{[1
]}

Moreau, Philippe ^{[1
]}

Attal, Michel ^{[2
]}

Avet-Loiseau, Herve ^{[2
]}

机构：

[1] CHU Nantes, Nantes, France

[2] CHU, Ctr Rech Cancerol Toulouse, INSERM, Inst Univ Canc, F-1037 Toulouse, France

来源：

LEUKEMIA | 2019年 / 33卷 / 02期

关键词：

PROTEIN ELECTROPHORESIS; MONOCLONAL GAMMOPATHIES; CELL TRANSPLANTATION; FOLLOW-UP; IMMUNOFIXATION; THERAPY; IMMUNOGLOBULINS; DISORDERS; DIAGNOSIS; CRITERIA;

D O I：

10.1038/s41375-018-0339-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The most recent update to the International Myeloma Working Group consensus criteria places a strong emphasis on the need for more sensitive haematological markers of response driven by the success of novel therapies. One such marker is serum free light chain (sFLC) analysis, which was first incorporated into the definition of stringent complete response in 2006. However, over the past decade there has been some reluctance to extend the role of the sFLC assays to replace 24 h urine electrophoresis for monitoring multiple myeloma (MM). In this review, we lay out the evidence in favour of serum over urine for monoclonal FLC measurements and propose modified criteria for response assignment in myeloma.

引用

页码：313 / 318

页数：6

共 45 条

[31] Pee no more? Urine light chains down the drain [J].

Mikhael, Joseph .

BLOOD, 2016, 128 (25) :2873-2874

[32] Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation [J].

Moesbauer, Ulrike ;

Ayuk, Francis ;

Schieder, Heike ;

Lioznov, Michael ;

Zander, Axel R. ;

Kroeger, Nicolaus .

HAEMATOLOGICA, 2007, 92 (02) :275-276

[33] Frontline therapy of multiple myeloma [J].

Moreau, Philippe ;

Attal, Michel ;

Facon, Thierry .

BLOOD, 2015, 125 (20) :3076-3084

[34] Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial [J].

Moreau, Philippe ;

Attal, Michel ;

Pegourie, Brigitte ;

Planche, Lucie ;

Hulin, Cyrille ;

Facon, Thierry ;

Stoppa, Anne-Marie ;

Fuzibet, Jean-Gabriel ;

Grosbois, Bernard ;

Doyen, Chantal ;

Ketterer, Nicolas ;

Sebban, Catherine ;

Kolb, Brigitte ;

Chaleteix, Carine ;

Dib, Mamoun ;

Voillat, Laurent ;

Fontan, Jean ;

Garderet, Laurent ;

Jaubert, Jerome ;

Mathiot, Claire ;

Esseltine, Dixie ;

Avet-Loiseau, Herve ;

Harousseau, Jean-Luc .

BLOOD, 2011, 117 (11) :3041-3044

[35] Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy [J].

Moustafa, M. Alhaj ;

Rajkumar, S. V. ;

Dispenzieri, A. ;

Gertz, M. A. ;

Lacy, M. Q. ;

Buadi, F. K. ;

Hwa, Y. L. ;

Dingli, D. ;

Kapoor, P. ;

Hayman, S. R. ;

Lust, J. A. ;

Kyle, R. A. ;

Kumar, S. K. .

LEUKEMIA, 2015, 29 (10) :2033-2038

[36] Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma [J].

Nowrousian, MR ;

Brandhorst, D ;

Sammet, C ;

Kellert, M ;

Daniels, R ;

Schuett, P ;

Poser, M ;

Mueller, S ;

Ebeling, P ;

Welt, A ;

Bradwell, AR ;

Buttkereit, U ;

Opalka, B ;

Flasshove, M ;

Moritz, T ;

Seeber, S .

CLINICAL CANCER RESEARCH, 2005, 11 (24) :8706-8714

[37] Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma [J].

Paiva, Bruno ;

Martinez-Lopez, Joaquin ;

Vidriales, Maria-Belen ;

Mateos, Maria-Victoria ;

Montalban, Maria-Angeles ;

Fernandez-Redondo, Elena ;

Alonso, Lourdes ;

Oriol, Albert ;

Teruel, Ana-Isabel ;

de Paz, Raquel ;

Larana, Jose-Garcia ;

Bengoechea, Enrique ;

Martin, Alejandro ;

Diaz Mediavilla, Joaquin ;

Palomera, Luis ;

de Arriba, Felipe ;

Blade, Joan ;

Orfao, Alberto ;

Lahuerta, Juan-Jose ;

San Miguel, Jesus F. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) :1627-1633

[38] International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma [J].

Rajkumar, S. Vincent ;

Dimopoulos, Meletios A. ;

Palumbo, Antonio ;

Blade, Joan ;

Merlini, Giampaolo ;

Mateos, Maria-Victoria ;

Kumar, Shaji ;

Hillengass, Jens ;

Kastritis, Efstathios ;

Richardson, Paul ;

Landgren, Ola ;

Paiva, Bruno ;

Dispenzieri, Angela ;

Weiss, Brendan ;

Leleu, Xavier ;

Zweegman, Sonja ;

Lonial, Sagar ;

Rosinol, Laura ;

Zamagni, Elena ;

Jagannath, Sundar ;

Sezer, Orhan ;

Kristinsson, Sigurdur Y. ;

Caers, Jo ;

Usmani, Saad Z. ;

Lahuerta, Juan Jose ;

Johnsen, Hans Erik ;

Beksac, Meral ;

Cavo, Michele ;

Goldschmidt, Hartmut ;

Terpos, Evangelos ;

Kyle, Robert A. ;

Anderson, Kenneth C. ;

Durie, Brian G. M. ;

San Miguel, Jesus F. .

LANCET ONCOLOGY, 2014, 15 (12) :E538-E548

[39] Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 [J].

Rajkumar, S. Vincent ;

Harousseau, Jean-Luc ;

Durie, Brian ;

Anderson, Kenneth C. ;

Dimopoulos, Meletios ;

Kyle, Robert ;

Blade, Joan ;

Richardson, Paul ;

Orlowski, Robert ;

Siegel, David ;

Jagannath, Sundar ;

Facon, Thierry ;

Avet-Loiseau, Herve ;

Lonial, Sagar ;

Palumbo, Antonio ;

Zonder, Jeffrey ;

Ludwig, Heinz ;

Vesole, David ;

Sezer, Orhan ;

Munshi, Nikhil C. ;

San Miguel, Jesus .

BLOOD, 2011, 117 (18) :4691-4695

[40] Utility of Serum Free Light Chain Analysis When Screening for Lymphoproliferative Disorders The Experience at a District General Hospital in the United Kingdom [J].

Robson, Ewan J. D. ;

Taylor, Joanne ;

Beardsmore, Claire ;

Basu, Supratik ;

Mead, Graham ;

Lovatt, Tracy .

LABMEDICINE, 2009, 40 (06) :325-329

← 1 2 3 4 5 →